Home > Insider Trading > Filing (0000950170-25-094572)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1800315	Galecto Inc.	GLTO	Pharmaceutical Preparations (2834)	371957007

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1808248	Lori Firmani	Ole Maaloes Vej 3 C/O Galecto, Inc. Copenhagen N G7 G7 DK-2200	Interim Cfo	No	No	No	No

Transaction Summary

Sold:	147 shares	Avg. Price: $3.39	Total Value: $498.33
Number of Shares After Transactions:	692 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-07-03	374	$0.00	839	No	4	M	Direct
Common Stock	Disposition	2025-07-03	147	$3.39	692	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2025-07-03	374	$0.00	374	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,100			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
Shares sold to cover tax obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its 2020 Equity Incentive Plan and does not represent a discretionary trade by the Reporting Person.
This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date.